Belinda Tan & Noah Craft, People Science, on enabling human-centered and clinically-rigorous testing for alternative medicines

The Pulse by Wharton Digital Health

In this episode, I sat down with Belinda Tan and Noah Craft, Co-Founders and Co-CEOs at People Science. Founded in 2019, People Science is a human-centered clinical research platform addressing the need for rigorous clinical science to back alternative medicines and wellness solutions that do not typically fall under traditional Western medicine. The company’s platform studies a range of solutions spanning microbiome and food-as-medicine interventions, natural and synthetic psychedelic medicines, cannabis and cannabinoids, functional medicines, and digital therapeutics. Its user-facing app called Chloe (Consumer Health Learning and Organizing Ecosystem) supports users to test these alternative treatments on themselves, and enables users to view personal results in real time while comparing themselves to others. People Science secured its $8.5 million seed funding through two rounds, most recently in December 2022.

Belinda, Noah and I discussed: 1) Their founding story and unique co-CEO leadership model, 2) The philosophy behind the People Science platform, including the nuances of alternative medicines compared to traditional Western medicine, 3) The business model, including both how studies are launched with B2B partners and the consumer-facing app (Chloe), and 4) Insights and advice from having co-founded and co-led not one, but two, companies together.